Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03489278 · ClinicalTrials.gov registry record

Clinical Procedures to Support Research in ALS

A clinical trial of Amyotrophic Lateral Sclerosis and Primary Lateral Sclerosis, sponsored by University of Miami.

Recruiting
Registry status
1,200
Enrollment target
11
Study locations

NCT03489278 is a study of Amyotrophic Lateral Sclerosis and Primary Lateral Sclerosis that is actively recruiting participants, run by University of Miami. The registered enrollment target is 1,200 participants, above the 886-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (35% higher). The trial reports 11 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03489278, a study of Amyotrophic Lateral Sclerosis and Primary Lateral Sclerosis, is actively recruiting participants, sponsored by University of Miami.

RECRUITING
Registry status
1,200 participants
Enrollment target
11
Study locations

Study Summary

The purpose of the Clinical Procedures To Support Research (CAPTURE) study is to utilize information collected in the medical record to learn more about a disease called amyotrophic lateral sclerosis (ALS) and related disorders.

Study Locations (11)

California

  • University of California, Irvine - Irvine
  • Stanford University - Palo Alto
  • California Pacific Medical Center - San Francisco

North Carolina

  • Duke University - Durham
  • Wake Forest University - Winston-Salem

Florida

  • University of Miami - Miami

Kansas

  • University of Kansas Medical Center - Kansas City

Minnesota

  • Hennepin County Medical Center - Minneapolis

New York

  • Columbia University - New York

Oregon

  • Providence Health & Services - Portland

Texas

  • University of Texas San Antonio Health Science Center - San Antonio

Trial Details

FieldValue
Enrollment Target 1,200 participants
Start Date 2018-02-15
Est. Completion 2027-06

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT03489278

The ClinicalTrials.gov registry entry for NCT03489278 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,200 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 886-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (35% higher). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Amyotrophic Lateral Sclerosis appearing as the primary indexed condition, and to 0 interventions.

NCT03489278 reports 11 study locations spanning 8 distinct geographic areas - top geographies include California, North Carolina, Florida.

Frequently Asked Questions

What is clinical trial NCT03489278 about?

NCT03489278 is a clinical study titled "Clinical Procedures to Support Research in ALS". The purpose of the Clinical Procedures To Support Research (CAPTURE) study is to utilize information collected in the medical record to learn more about a disease called amyotrophic lateral sclerosis (ALS) and related disorders.

What is the current status of trial NCT03489278?

This trial is currently recruiting. The enrollment target is 1,200 participants. The study started on 2018-02-15. Estimated completion is 2027-06.

What conditions does trial NCT03489278 study?

This clinical trial studies the following conditions: Amyotrophic Lateral Sclerosis, Primary Lateral Sclerosis, Progressive Muscular Atrophy, ALS-Frontotemporal Dementia.

Who is sponsoring clinical trial NCT03489278?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03489278 being conducted?

This trial has 11 study locations across California, Florida, Kansas, Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Amyotrophic Lateral Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.